Search clinical trials for: GONAL-f®

Total 15566 results

Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Infertility

China
Dong-A ST Co., Ltd.

Completed

A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Infertility | Anovulation

Korea, Republic of
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

Infertility

China
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

Cyprus
Reproductive Specialists of New York

Completed

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

Infertility
University of California, San Diego

Active, not recruiting

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

Cancer | Infertility

United States
Ferring Pharmaceuticals

Completed

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Infertility

Belgium, Denmark, Spain, Czechia
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

Infertility

Canada
Hangzhou YuYuan Bioscience Technology Co., Ltd.
LG Chem

Completed

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Infertility, Female

China
U.O. Chirurgia Andrologica
Androcenter, Napoli, Italy

Unknown

Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery

Infertility, Male | Varicocele
GeneScience Pharmaceuticals Co., Ltd.
Peking University First Hospital; Peking University People's Hospital; Qilu Hospital... and other collaborators

Completed

Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation

Anovulation
Sisli Hamidiye Etfal Training and Research Hospital
Selcuk University

Completed

The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI (LH)

Infertility
Merck KGaA, Darmstadt, Germany

Completed

CONSORT Randomized Controlled Trial in Assisted Reproductive Technology

Infertility

Switzerland
Polymun Scientific GmbH

Completed

Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application

Healthy
Vietnam National University
Merck Serono Vietnam

Completed

Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study

Infertility

Vietnam
Merckle GmbH

Completed

Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women

Bioequivalence
IBSA Institut Biochimique SA

Completed

Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF

Infertility

United States
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Terminated

EXpression PRofile Endometrium Samples Study (EXPRESS)

In Vitro Fertilization

France
Cliniques universitaires Saint-Luc- Université...

Recruiting

Tailored Ovarian Stimulation Based on BMI, AMH, AFC

Infertility

Belgium
Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan

Terminated

Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen

Infertility

Taiwan
Merck KGaA, Darmstadt, Germany

Completed

An Observational Study of Gonal-F Filled by Mass Pens in Multifollicular Stimulation Prior to In-vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI)

Multifollicular Stimulation

Korea, Republic of
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Terminated

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Infertility | Fertility | Follicle Stimulating Hormone Deficiency

United Arab Emirates
Peking University Third Hospital
Peking Union Medical College Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation

Infertility

China
Ferring Pharmaceuticals

Completed

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population (MEGASET HR)

Infertility

United States
University of Aarhus
Odense University Hospital; Ferring Pharmaceuticals; Herlev Hospital; The Fertility... and other collaborators

Terminated

Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.

Patients for In Vitro Fertilization(IVF)Treatment

Denmark
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

Infertility

Argentina
Centre Hospitalier Chretien
EMD Serono

Withdrawn

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

Infertility

Belgium
Merck KGaA, Darmstadt, Germany

Completed

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization (Prestyje)

Infertility | Ovulation Induction | In-Vitro Fertilization

Germany
Assistance Publique - Hôpitaux de Paris
MerckSerono Pharmaceuticals

Completed

NATural Ovarian Stimulation (NATOS)

Infertility

France
Fertility Biotech AG

Completed

Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application

Healthy Volunteers

United Kingdom
Rigshospitalet, Denmark
Odense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaborators

Completed

Nordic Luveris Study

Infertility | In Vitro Fertilization

Denmark
Alphamab Jilin Co., Ltd.

Unknown

Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women

Infertility, Female
Fertility Biotech AG

Completed

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Infertility

United States
Universitair Ziekenhuis Brussel

Recruiting

Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin (IVM-FSHhCG)

In Vitro Maturation of Oocytes

Belgium
Ferring Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program

Infertility

China
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaborators

Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

Assisted Reproductive Techniques | Reproductive Technology, Assisted

Italy, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ-LLC, United Arab Emirates, an affiliate of Merck...

Completed

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Ovulation Induction

Kuwait, Lebanon, Saudi Arabia
Mansoura University

Unknown

FSH Followed by HMG vs FSH Plus HMG in IVF

IVF

Egypt
University of Turin, Italy

Completed

Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization

Infertility

Italy
Catholic University of the Sacred Heart

Completed

Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.

Female Infertility

Italy
Gilead Sciences

Recruiting

Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)

HIV-1-infection

United States, France, Canada
Tulika Singh, MD
Gilead Sciences

Recruiting

Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age

HIV-1-infection

United States
Ferring Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (Compass)

Anovulation

China
Merck KGaA, Darmstadt, Germany

Terminated

Low-dose Gonal-f® in Ovulation Induction (LoGo)

Infertility | Monofollicular Development

United Kingdom, Ireland
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)

Infertility

Greece
Johnson & Johnson Consumer and Personal Products...

Completed

To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children

Atopic Dermatitis

United States
Gilead Sciences

Completed

Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women

HIV-1 Infection

Russian Federation, United States, Thailand, Uganda, Puerto Rico, Dominican Republic
Gilead Sciences

Recruiting

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

HIV-1 Infection

United States, Thailand, Uganda, South Africa
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (ESPART)

Infertility

Germany

3

Subscribe